All of these upstream regulators have been shown to be involved in NASH progression, lending weight to the hypothesis that Insig1 downregulation might directly/indirectly lead to a pleiotropic protective set of mechanisms that attenuate inflammation and liver damage in NAFLD [41,42]. The gene discussed is INSIG1; the disease is metabolic dysfunction-associated steatohepatitis.